Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Giustolisi

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Blood|June 15, 1990
Blood hypercoagulability as a risk factor for leg ulcers in sickle cell diseaseE Cacciola, R Musso, R Giustolisi, et al.
Acta Haematologica|June 16, 2001
Successful treatment of granulocytic sarcoma with alpha-interferon and disodium pamidronate at presentation of chronic myeloid leukemiaF Stagno, P Guglielmo, U Consoli, et al.
Haematologica|November 1, 1992
Alpha interferon as first line therapy for angioimmunoblastic lymphoadenopathy. Possible value of DR+ cells in monitoring therapeutical responseG Milone, P Guglielmo, E Cacciola, et al.
Acta Haematologica|January 30, 2002
Angiogenesis in chronic myeloproliferative diseasesF Di Raimondo, G A Palumbo, S Molica, et al.
Annals of Internal Medicine|September 15, 1989
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot studyE Cacciola, R Giustolisi, R Musso, et al.
British Journal of Haematology|August 1, 1985
Treatment of CML blast crisis with low dose ARA-CF di Raimondo, G Milone, P Guglielmo, et al.
Acta Haematologica|January 1, 1986
Low-dose cytarabine in myelodysplastic syndromes and acute leukemia. A commentE Cacciola, F Di Raimondo, P Guglielmo, et al.
Haematologica|October 1, 1982
Combination chemotherapy ("MABOP") in advanced refractory lymphocytic lymphoma with unfavorable histologyR Giustolisi, P Guglielmo, F Di Raimondo, et al.
Haematologica|June 1, 1982
Evidence that mouse receptor on lymphocytes from chronic lymphocytic leukaemia might be an IgM-receptor (mu Fc-R)P Guglielmo, R Giustolisi, F Di Raimondo, et al.
Blood|February 24, 2001
Angiogenesis in acute myeloid leukemiaF Di Raimondo, G A Palumbo, M P Azzaro, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Blood|June 15, 1990
Blood hypercoagulability as a risk factor for leg ulcers in sickle cell diseaseE Cacciola, R Musso, R Giustolisi, et al.
Acta Haematologica|June 16, 2001
Successful treatment of granulocytic sarcoma with alpha-interferon and disodium pamidronate at presentation of chronic myeloid leukemiaF Stagno, P Guglielmo, U Consoli, et al.
Haematologica|November 1, 1992
Alpha interferon as first line therapy for angioimmunoblastic lymphoadenopathy. Possible value of DR+ cells in monitoring therapeutical responseG Milone, P Guglielmo, E Cacciola, et al.
Acta Haematologica|January 30, 2002
Angiogenesis in chronic myeloproliferative diseasesF Di Raimondo, G A Palumbo, S Molica, et al.
Annals of Internal Medicine|September 15, 1989
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot studyE Cacciola, R Giustolisi, R Musso, et al.
British Journal of Haematology|August 1, 1985
Treatment of CML blast crisis with low dose ARA-CF di Raimondo, G Milone, P Guglielmo, et al.
Acta Haematologica|January 1, 1986
Low-dose cytarabine in myelodysplastic syndromes and acute leukemia. A commentE Cacciola, F Di Raimondo, P Guglielmo, et al.
Haematologica|October 1, 1982
Combination chemotherapy ("MABOP") in advanced refractory lymphocytic lymphoma with unfavorable histologyR Giustolisi, P Guglielmo, F Di Raimondo, et al.
Haematologica|June 1, 1982
Evidence that mouse receptor on lymphocytes from chronic lymphocytic leukaemia might be an IgM-receptor (mu Fc-R)P Guglielmo, R Giustolisi, F Di Raimondo, et al.
Blood|February 24, 2001
Angiogenesis in acute myeloid leukemiaF Di Raimondo, G A Palumbo, M P Azzaro, et al.
Pageof 8